Subscribe to RSS
COVID-19 in Egyptian Children: A Multicenter Study
Objective The novel coronavirus disease 2019 (COVID-19) has made its worldwide spread since its outbreak in December 2019. Limited information is available about the epidemiology and clinical characteristics of COVID-19, especially in Africa and Egypt.
Methods We aimed to study the clinical and epidemiological characteristics of COVID-19 in Egyptian children. This is an observational retrospective cohort study performed at two specialized COVID-19 isolation hospitals in Egypt. All admitted COVID-19 pediatric patients between March 20, 2020, and May 1, 2020, were included in the study.
Discussion This study included 40 COVID-19 confirmed cases (mean age, 9.4 years), 67.5% were male, 85% were asymptomatic, and 15% had mild symptoms. There were no confirmed severe or critically ill cases among the patients.
Conclusion COVID-19 runs in a benign course in Egyptian children with no mortality and no significant morbidity.
Received: 11 July 2020
Accepted: 29 November 2020
01 February 2021 (online)
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
- 1 Wu P, Hao X, Lau EHY. et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill 2020; 25 (03) 2000044
- 2 Hassany M, Abdel-Razek W, Asem N, AbdAllah M, Zaid H. Estimation of COVID-19 burden in Egypt. Lancet Infect Dis 2020; 20 (08) 896-897
- 3 The Egyptian Ministry of Health official report. 2020 . Available at: http://www.mohp.gov.eg
- 4 Chan JFW, Yuan S, Kok KH. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395 (10223): 514-523
- 5 Su L, Ma X, Yu H. et al. The different clinical characteristics of corona virus disease cases between children and their families in China - the character of children with COVID-19. Emerg Microbes Infect 2020; 9 (01) 707-713
- 6 Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020; 109 (06) 1088-1095
- 7 Ji LN, Chao S, Wang YJ. et al. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases. World J Pediatr 2020; 16 (03) 267-270
- 8 Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020; 20 (06) 689-696
- 9 Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA 2020; 323 (14) 1335
- 10 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13) 1239-1242
- 11 Tagarro A, Epalza C, Santos M. et al. Screening and severity of coronavirus Disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr 2020; (e-pub ahead of print). DOI: 10.1001/jamapediatrics.2020.1346.
- 12 Population Pyramids of the World from 1950 to 2100: Egypt 2019. Accessed December 14, 2020 at: https://www.populationpyramid.net/egypt/2019/
- 13 Salman S, Salem ML. Routine childhood immunization may protect against COVID-19. Med Hypotheses 2020; 140: 109689
- 14 Schouten LR, van Kaam AH, Kohse F. et al; MARS consortium. Age-dependent differences in pulmonary host responses in ARDS: a prospective observational cohort study. Ann Intensive Care 2019; 9 (01) 55
- 15 Chun Y, Do A, Grishina G. et al. Integrative study of the upper and lower airway microbiome and transcriptome in asthma. JCI Insight 2020; 5 (05) e133707
- 16 Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin-converting Enzyme 2 in children and adults. JAMA 2020; 323 (23) 2427-2429
- 17 Dong Y, Mo X, Hu Y. et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020; 145 (06) e20200702
- 18 Bialek S, Boundy E, Bowen V. et al; CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States. Morb Mortal Wkly Rep 2020; 69 (12) 343-346
- 19 Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med 2020; 58 (07) 1135-1138
- 20 Xu Y, Li X, Zhu B. et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 2020; 26 (04) 502-505
- 21 Chen F, Liu ZS, Zhang FR. et al. [First case of severe childhood novel coronavirus pneumonia in China] (in Chinese). Zhonghua Er Ke Za Zhi 2020; 58 (00) E005
- 22 Feng K, Yun YX, Wang XF. et al. [Analysis of CT features of 15 children with 2019 novel coronavirus infection] (in Chinese). Zhonghua Er Ke Za Zhi 2020; 58 (00) E007
- 23 Jin JM, Bai P, He W. et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020; 8: 152
- 24 Yao X, Ye F, Zhang M. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020; 71 (15) 732-739
- 25 Juurlink DN. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ 2020; 192 (17) E450-E453
- 26 Chiotos K, Hayes M, Kimberlin DW. et al. Multicenter interim guidance on use of antivirals for children with COVID-19/SARS-CoV-2. J Pediatr Infect Dis Soc 2021; 10 (01) 34-48